Search Results - "Field, Julie R."

Refine Results
  1. 1
  2. 2

    Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants by Henry, L. Keith, Field, Julie R., Adkins, Erika M., Parnas, M. Laura, Vaughan, Roxanne A., Zou, Mu-Fa, Newman, Amy H., Blakely, Randy D.

    Published in The Journal of biological chemistry (27-01-2006)
    “…In previous studies examining the structural determinants of antidepressant and substrate recognition by serotonin transporters (SERTs), we identified Tyr-95…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Targeting glutamate synapses in schizophrenia by Field, Julie R, Walker, Adam G, Conn, P. Jeffrey

    Published in Trends in molecular medicine (01-12-2011)
    “…Although early clinical observations implicated dopamine dysfunction in the neuropathology of schizophrenia, accumulating evidence suggests that multiple…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Electronic health record design and implementation for pharmacogenomics: a local perspective by Peterson, Josh F., Bowton, Erica, Field, Julie R., Beller, Marc, Mitchell, Jennifer, Schildcrout, Jonathan, Gregg, William, Johnson, Kevin, Jirjis, Jim N., Roden, Dan M., Pulley, Jill M., Denny, Josh C.

    Published in Genetics in medicine (01-10-2013)
    “…The design of electronic health records to translate genomic medicine into clinical care is crucial to successful introduction of new genomic services, yet…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program by Schildcrout, Jonathan S, Shi, Yaping, Danciu, Ioana, Bowton, Erica, Field, Julie R, Pulley, Jill M, Basford, Melissa A, Gregg, William, Cowan, James D, Harrell, Frank E, Roden, Dan M, Peterson, Josh F, Denny, Joshua C

    Published in Journal of clinical epidemiology (01-04-2016)
    “…Abstract Objectives We describe the development, implementation, and evaluation of a model to pre-emptively select patients for genotyping based on medication…”
    Get full text
    Journal Article
  11. 11

    Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine by Field, Julie R., Henry, L. Keith, Blakely, Randy D.

    Published in The Journal of biological chemistry (09-04-2010)
    “…The plasma membrane serotonin (5-HT) transporter (SERT, SLC6A4) clears 5-HT after release at nerve termini and is targeted by both antidepressant medications…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies by Kaufmann, Kristian W., Dawson, Eric S., Henry, L. Keith, Field, Julie R., Blakely, Randy D., Meiler, Jens

    “…To identify potential determinants of substrate selectivity in serotonin (5‐HT) transporters (SERT), models of human and Drosophila serotonin transporters…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Dopamine signaling architecture in Caenorhabditis elegans by McDonald, Paul W, Jessen, Tammy, Field, Julie R, Blakely, Randy D

    Published in Cellular and molecular neurobiology (01-07-2006)
    “…In this review, we highlight the identification and analysis of molecules orchestrating dopamine (DA) signaling in the nematode Caenorhabditis elegans,…”
    Get full text
    Journal Article
  18. 18

    Y95 and E444 Interaction Required for High-Affinity S-Citalopram Binding in the Human Serotonin Transporter by Combs, Steven, Kaufmann, Kristian, Field, Julie R, Blakely, Randy D, Meiler, Jens

    Published in ACS chemical neuroscience (16-02-2011)
    “…The human serotonin (5-hydroxytryptamine, 5-HT) transporter (hSERT) is responsible for the reuptake of 5-HT following synaptic release, as well as for import…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Physician response to implementation of genotype-tailored antiplatelet therapy by Peterson, JF, Field, JR, Unertl, KM, Schildcrout, JS, Johnson, DC, Shi, Y, Danciu, I, Cleator, JH, Pulley, JM, McPherson, JA, Denny, JC, Laposata, M, Roden, DM, Johnson, KB

    Published in Clinical pharmacology and therapeutics (01-07-2016)
    “…Physician responses to genomic information are vital to the success of precision medicine initiatives. We prospectively studied a pharmacogenomics…”
    Get full text
    Journal Article